We also evaluated IC50 values for afatinib in gefitinib-resistant human lung cancer H1975 cells carrying de novo T790M mutation, and in H460 cells which express wild-type of EGFR but carrying KRAS mutation which leads to gefitinib resistance. This evidence concerns the gene EGFR and lung carcinoma.